In this free webinar, learn about the impact of cell and gene therapies on the current standard of care for patients with autoimmune disease. Attendees will delve into the rapid advancements in ...
GSI Technology (NASDAQ:GSIT) reported its third-quarter fiscal 2025 earnings, revealing a 2% year-over-year revenue increase to $5.4 million, along with notable improvements in net loss figures.
A timely report on governance in South Africa's healthcare sector released last year identified several serious shortcomings. As the political and administrative wheels again start turning in 2025, we ...